Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Palladium Network Palladium Network +6.43%
#3 Cryptopia Cryptopia +4.36%
#4 SIXSEVEN SIXSEVEN +4.11%
#5 GRVT Token GRVT Token +3.87%
#6 Jito Jito +3.53%
#7 Kinetiq Kinetiq +3.41%
#8 Test Test +3.32%
#9 Movement Movement +3.31%
#10 Victoria VR Victoria VR +3.17%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
OncoVista Innovative Therapies, Inc. OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies, Inc.

OVIT
Rank in Stocks #42301
OncoVista Innovative Therapies, Inc. does not have significant business.... OncoVista Innovative Therapies, Inc. does not have significant business. Previously, it engaged in development of targeted anticancer therapies by utilizing tumor-associated biomarkers. The company was founded in 2004 and is based in San Antonio, Texas.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$2.36K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade OncoVista Innovative Therapies, Inc. (OVIT)

Category

Healthcare
Earnings for OncoVista Innovative Therapies, Inc. (OVIT)
Earnings in 2026 TTM: 0
According to OncoVista Innovative Therapies, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for OncoVista Innovative Therapies, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR